Single-use bioreactors, which are ideally suited for manufacturing biopharmaceutical products because of their high-performance, have become highly evolved these days thanks to constant efforts by players to develop products. They are seen working on improving designs, sensor systems, film technology, and stirring mechanism of single-use bioreactors. In doing so, they are factoring in the specific requirements of their clients vis-à-vis gene and cell therapies and for continued bioprocessing.
Some of the prominent participants in the global single-use bioreactors market are Stedim Biotech, Sartorius Merck Millipore, Thermo Fisher Scientific, GE Healthcare, Celltainer Biotech, Danaher, Applikon Biotechnology, Parker Hannifin, Cesco Bioengineering, PBS Biotech, Cellexus, Distek, Pierre Guerin, Eppendorf, and Solida Biotech.
Transparency Market Research (TMR), which recently prepared a report on the global market for single-use bioreactors, finds that it is primed for good growth over the course of the forecast period between 2017 and 2026. It states that by registering a CAGR of 13.5%, the market will likely reach a value of US$1.55 bn by the end of 2026.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) : https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2108
The different types of single-use bioreactors available in the market are media bags, filtration assemblies, and single use bioreactor systems. The single use bioreactor systems of them are expected to expand at a healthy clip in the next couple of years. Media bags form another attractive product segment and together with single use bioreactor systems, is expected to generate over half the revenue in the market.
North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa are some of the prominent regions in the global market for single-use bioreactors. Europe, of them, leads the market because of the presence of some of the well-known pharmaceutical companies in the region. Supportive policies meant to boost efforts by biopharmaceutical companies to come up with new therapies in biologics is also benefitting the market in the region along with the rising application of single-use bioreactors in cell culture-based manufacturing.
Manufacturers Focus on Fixing Product Issues to Generate New Growth Avenues
Commercial considerations are mostly driving the use of single-use bioreactors. Manufacturers are keen to ensure that their products bring about cost savings in biopharmaceutical companies. “While single-use bioreactor bags are generating pathways that can manufacture protein-based drugs securely, the compounds or materials have a tendency to leak on account of the extrusion process that makes the bag films thin. Fixing of such risks by stabilizing the materials has spelt new opportunities for savvy companies trying to increase their sales,” explains the TMR analyst who prepared the report.
REQUEST FOR COVID19 IMPACT ANALYSIS – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2108
Biopharmaceutical Firms at the Forefront of Driving Demand
Depending upon end user, the biopharmaceutical companies are predicted to generate maximum demand. Currently, players are focusing on designing new generation single-use bioreactors, keeping in mind the final drug product required by end users.
Recent developments in single-use bioreactors by manufacturers are focused on improving mixing, bringing down complexity, and avoiding leakage, and other integrity issues. Apart from that, bettering cell-culture processes are also driving rising adoption of single-use bioreactors.
This review is based on the findings of a TMR report, titled, “Single-Use Bioreactors Market (Product Type – Single Use Bioreactor Systems, Media Bags, Filtration Assemblies, Other Products; End User – Biopharmaceutical Companies, Biotechnology Companies, Other End Users; Cells Type- Mammalian Cells, Bacterial Cells, Yeast Cells, Other Cells; Molecule Type- Monoclonal Antibodies (MABS), Vaccines, Stem Cells, Gene-Modified Cells, Other Molecules) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017–2026.”
More Trending Reports by Transparency Market Research – http://www.prnewswire.com/news-releases/high-focus-on-joint-health-of-race-horses-spurring-growth-in-equine-supplement-products-market-transparency-market-research-301008207.html
The global single-use bioreactors market has been segmented in the following manner:
Global Single-Use Bioreactors Market, by Product
- Single Use Bioreactor Systems
- Media Bags
- Filtration Assemblies
Global Single-Use Bioreactors Market, by End User
- Biopharmaceutical Companies
- Biotechnology Companies
Global Single-Use Bioreactors Market, by Cell Type
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
- Other Cells
Global Single-Use Bioreactors Market, by Molecule Type
- Monoclonal Antibodies (MABS)
- Stem Cells
- Gene-Modified Cells
- Other Molecules
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453